Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-07 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 9e-05 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |